샘플 요청 목록

 카트 문의
시장보고서
상품코드
1545562

세계의 보조생식기술 시장

Assisted Reproductive Technology
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 179 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보조생식기술 세계 시장 규모는 2030년까지 276억 달러에 달할 것으로 전망

2023년 197억 달러로 추정되는 보조생식기술 세계 시장은 2030년 276억 달러에 달할 것으로 예상되며, 2023-2030년 동안 4.9%의 CAGR을 기록할 것으로 예상됩니다. 이 보고서에서 분석한 부문 중 하나인 체외수정(IVF)은 5.0%의 CAGR을 기록하여 분석 기간 종료 시점에 220억 달러에 달할 것으로 예상됩니다. 냉동 배아 교환(FER) 분야의 성장률은 분석 기간 동안 CAGR 4.5 %로 추정됩니다.

미국 시장 53억 달러로 추정, 중국은 CAGR 4.8%로 성장 전망

미국의 보조생식기술 시장은 2023년 53억 달러에 달할 것으로 추정됩니다. 세계 2위의 경제 대국인 중국은 2030년까지 44억 달러의 시장 규모에 도달할 것으로 예상되며, 2023-2030년 분석 기간 동안 4.8%의 CAGR을 기록할 것으로 예상됩니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안 각각 4.6%와 3.8%의 CAGR을 기록할 것으로 예상됩니다. 유럽에서는 독일이 4.0%의 CAGR로 성장할 것으로 예상됩니다.

세계 보조생식기술 시장 - 주요 동향 및 촉진요인 정리

보조생식기술은 현대 불임 치료를 어떻게 변화시키고 있는가?

보조생식기술(ART)은 불임 치료 분야에 혁명을 일으켜 불임으로 고통받는 수백만 명의 개인과 부부에게 희망을 가져다 주었으며, ART는 불임 치료에 사용되는 다양한 의료 행위를 포함하며, 체외수정(IVF)이 가장 잘 알려져 있고 널리 사용되는 방법입니다. 이 기술은 난자, 정자, 배아를 조작하여 임신을 달성하는 것으로, 자연 임신에 어려움을 겪고 있는 사람들에게 새로운 가능성을 가져다주었습니다. 난자 세포질 내 정자 주입(ICSI), 착상 전 유전자 검사(PGT), 난자 동결 등 기술의 발전으로 성공률이 비약적으로 높아졌고, 환자들의 선택의 폭이 넓어졌습니다. 맞춤형 솔루션을 제공하고 있습니다.

ART의 성공률을 높이는 기술 혁신이란?

기술 혁신은 보조생식기술의 성공률을 높이고, 보다 친숙하고 효과적인 치료법을 만드는 데 중요한 역할을 하고 있습니다. 타임랩스 영상과 인공지능(AI)을 이용한 배아 품질 평가 등 배아 배양 기술의 발전은 이식 시 가장 생존 가능성이 높은 배아를 선별하는 능력을 향상시켜 임신 성공 가능성을 높이고 있습니다. 또한, 보다 정교한 호르몬 자극 프로토콜의 개발로 난소과자극증후군(OHSS)의 위험이 감소하고 체외수정 환자의 예후가 개선되고 있습니다. 또한 냉동 보존 기술, 특히 유리화 기술의 혁신으로 냉동 난자 및 냉동 배아의 생존율이 크게 향상되어 보다 유연한 치료 일정과 생식 능력 보존이 가능해졌습니다. 이러한 기술의 발전은 성공률을 높일 뿐만 아니라 복잡한 불임 환자나 출산을 늦추고자 하는 환자 등 더 많은 환자들에게 ART를 더 신뢰할 수 있는 선택으로 만들고 있습니다.

어떤 시장 동향이 보조생식기술의 채택을 촉진하고 있는가?

보조생식기술의 보급을 촉진하는 몇 가지 중요한 시장 동향은 가족계획과 생식 의료의 발전에 대한 사회적 인식의 변화를 반영하는 몇 가지 중요한 시장 동향을 반영하고 있습니다. 직업의 우선순위와 사회적 규범의 변화로 인해 부모가 되는 시기를 늦추려는 경향이 강해지면서 난자 냉동과 같은 가임력 보존 옵션에 대한 수요가 증가하고 있습니다. 또한, 동성 커플과 한부모 가정 사이에서 ART에 대한 인식과 수용도가 높아지면서 불임 치료 시장이 확대되고 있습니다. 의료 관광의 성장, 특히 ART를 더 저렴하게 이용할 수 있거나 특정 치료를 더 쉽게 받을 수 있는 국가들의 성장도 전 세계적으로 ART 서비스를 확대하는 데 기여하고 있습니다. 또한, 환자 개개인의 필요와 상황에 맞는 맞춤형 치료 계획을 원하는 환자가 증가함에 따라 개인 맞춤형 의료의 흐름이 ART 시장에 영향을 미치고 있습니다.

보조생식기술 시장의 성장을 촉진하는 요인은 무엇일까?

보조생식기술 시장의 성장은 불임 치료의 상황을 변화시키고 있는 몇 가지 요인에 의해 주도되고 있습니다. 주요 요인으로는 출산 지연, 생활습관 변화, 생식 건강에 영향을 미치는 환경적 요인 등의 영향으로 인한 불임 유병률 증가를 들 수 있습니다. 배아 선택, 냉동 보존, 유전자 검사 등 ART의 기술 발전은 성공률을 높이고 더 많은 환자들에게 이러한 치료의 매력을 넓혀주고 있습니다. 또한, 불임 치료에 대한 접근성이 확대되고 있는 신흥 시장에서의 ART 서비스 확대도 시장 성장에 기여하고 있습니다. 또한, 출산 지연과 가족 계획의 유연성을 추구하는 추세로 인해 가임력 보존 옵션에 대한 수요가 증가하고 있는 것도 ART 도입에 힘을 실어주고 있습니다. 이러한 요인들이 계속 진화하는 가운데, ART 시장은 기술 혁신, 사회적 규범의 변화, 효과적인 불임 치료 솔루션에 대한 수요 증가로 인해 지속적인 성장이 예상됩니다.

조사 대상 기업 예시(총 11건)

  • Bloom Fertility Centre
  • Cosmos Biomedical Ltd.
  • Cryolab Ltd.
  • European Sperm Bank ApS
  • Ferring Pharmaceuticals
  • Irvine Scientific
  • Microm UK Ltd
  • ORIGIO A/S
  • Ovascience Inc.
  • Parallabs Limited

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 성장 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

제4장 경쟁

ksm 24.09.10

Global Assisted Reproductive Technology Market to Reach US$27.6 Billion by 2030

The global market for Assisted Reproductive Technology estimated at US$19.7 Billion in the year 2023, is expected to reach US$27.6 Billion by 2030, growing at a CAGR of 4.9% over the analysis period 2023-2030. In-Vitro Fertilization (IVF), one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$22.0 Billion by the end of the analysis period. Growth in the Frozen Embryo Replacement (FER) segment is estimated at 4.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$5.3 Billion While China is Forecast to Grow at 4.8% CAGR

The Assisted Reproductive Technology market in the U.S. is estimated at US$5.3 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$4.4 Billion by the year 2030 trailing a CAGR of 4.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.6% and 3.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.0% CAGR.

Global Assisted Reproductive Technology Market - Key Trends and Drivers Summarized

How Is Assisted Reproductive Technology Transforming Modern Fertility Treatments?

Assisted Reproductive Technology (ART) has revolutionized the field of fertility treatments, offering hope to millions of individuals and couples struggling with infertility. ART encompasses a range of medical procedures used to treat infertility, with in vitro fertilization (IVF) being the most well-known and widely used method. These technologies involve the manipulation of eggs, sperm, or embryos to achieve pregnancy, and have opened up new possibilities for those facing challenges in conceiving naturally. ART has advanced significantly since its inception, with improvements in techniques such as intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and egg freezing, which have dramatically increased success rates and expanded the options available to patients. As ART becomes more sophisticated, it continues to push the boundaries of what is possible in reproductive medicine, providing personalized solutions that cater to the unique needs of each patient.

What Technological Innovations Are Enhancing the Success Rates of ART?

Technological innovations have played a critical role in enhancing the success rates of Assisted Reproductive Technology, making these treatments more accessible and effective. Advances in embryo culture techniques, such as time-lapse imaging and the use of artificial intelligence (AI) to assess embryo quality, have improved the ability to select the most viable embryos for transfer, increasing the likelihood of a successful pregnancy. The development of more refined hormonal stimulation protocols has also reduced the risk of ovarian hyperstimulation syndrome (OHSS) and improved outcomes for patients undergoing IVF. Additionally, innovations in cryopreservation, particularly vitrification, have significantly improved the survival rates of frozen eggs and embryos, allowing for more flexible treatment schedules and better preservation of reproductive potential. These technological advancements are not only boosting success rates but also making ART a more reliable option for a broader range of patients, including those with complex infertility issues or those who wish to delay childbearing.

What Market Trends Are Driving the Adoption of Assisted Reproductive Technology?

Several key market trends are driving the adoption of Assisted Reproductive Technology, reflecting broader changes in societal attitudes towards family planning and advancements in reproductive medicine. The increasing trend towards delayed parenthood, driven by career priorities and changing social norms, has led to a growing demand for fertility preservation options such as egg freezing, which is now often included as part of ART services. Additionally, the rising awareness and acceptance of ART among same-sex couples and single parents have expanded the market for fertility treatments, as these groups seek options to build their families. The growth of medical tourism, particularly in countries where ART is more affordable or where certain treatments are more readily available, is also contributing to the global expansion of ART services. Furthermore, the ongoing trend towards personalized medicine is influencing the ART market, as patients increasingly seek tailored treatment plans that align with their specific needs and circumstances.

What Factors Are Driving the Growth of the Assisted Reproductive Technology Market?

The growth in the Assisted Reproductive Technology market is driven by several factors that are reshaping the landscape of fertility treatments. A primary driver is the increasing prevalence of infertility, influenced by factors such as delayed childbearing, lifestyle changes, and environmental factors that impact reproductive health. Technological advancements in ART, including improvements in embryo selection, cryopreservation, and genetic testing, are enhancing success rates and broadening the appeal of these treatments to a wider range of patients. The expansion of ART services in emerging markets, where access to fertility treatments is becoming more widespread, is also contributing to market growth. Additionally, the rise in demand for fertility preservation options, driven by trends such as delayed parenthood and the desire for family planning flexibility, is boosting the adoption of ART. As these factors continue to evolve, the ART market is expected to experience sustained growth, driven by innovation, changing societal norms, and the increasing need for effective fertility solutions.

Select Competitors (Total 11 Featured) -

  • Bloom Fertility Centre
  • Cosmos Biomedical Ltd.
  • Cryolab Ltd.
  • European Sperm Bank ApS
  • Ferring Pharmaceuticals
  • Irvine Scientific
  • Microm UK Ltd
  • ORIGIO A/S
  • Ovascience Inc.
  • Parallabs Limited

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Assisted Reproductive Technology - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Infertility Rates Propel Growth in Assisted Reproductive Technology
    • Advancements in Embryo Selection Strengthen Business Case for ART
    • Increasing Demand for Egg Freezing Expands Addressable Market Opportunity
    • Shift Towards Delayed Parenthood Spurs Growth in Fertility Preservation Services
    • Growth in Same-Sex Couple Family Planning Drives Adoption of ART
    • Innovation in Genetic Testing Techniques Accelerates Demand for Tailored ART Solutions
    • Rising Acceptance of ART Among Single Parents Expands Market Reach
    • Global Medical Tourism Throws the Spotlight on Affordable ART Options
    • Improvement in Cryopreservation Techniques Sustains Growth in ART Market
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Fertility Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Fertility Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Fertility Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Assisted Reproductive Technology Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Assisted Reproductive Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Assisted Reproductive Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for In-Vitro Fertilization (IVF) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for In-Vitro Fertilization (IVF) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for In-Vitro Fertilization (IVF) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Frozen Embryo Replacement (FER) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Frozen Embryo Replacement (FER) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Frozen Embryo Replacement (FER) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Artificial Insemination-Intrauterine Insemination (AI-IUI) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Artificial Insemination-Intrauterine Insemination (AI-IUI) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Artificial Insemination-Intrauterine Insemination (AI-IUI) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Fresh Non-Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Fresh Non-Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Fresh Non-Donor by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Frozen Non-Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Frozen Non-Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Frozen Non-Donor by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Embryo / Egg Banking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Embryo / Egg Banking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Embryo / Egg Banking by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Frozen Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Frozen Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for Frozen Donor by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Fresh Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Fresh Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: World 16-Year Perspective for Fresh Donor by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Assisted Reproductive Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Assisted Reproductive Technology by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Assisted Reproductive Technology by Type - Percentage Breakdown of Value Sales for In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types for the Years 2014, 2024 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: USA 16-Year Perspective for Assisted Reproductive Technology by Procedure - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Assisted Reproductive Technology by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Canada 16-Year Perspective for Assisted Reproductive Technology by Type - Percentage Breakdown of Value Sales for In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types for the Years 2014, 2024 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Canada 16-Year Perspective for Assisted Reproductive Technology by Procedure - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor for the Years 2014, 2024 & 2030
  • JAPAN
    • Assisted Reproductive Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Assisted Reproductive Technology by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Japan 16-Year Perspective for Assisted Reproductive Technology by Type - Percentage Breakdown of Value Sales for In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types for the Years 2014, 2024 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Japan 16-Year Perspective for Assisted Reproductive Technology by Procedure - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor for the Years 2014, 2024 & 2030
  • CHINA
    • Assisted Reproductive Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 68: China Recent Past, Current & Future Analysis for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: China 16-Year Perspective for Assisted Reproductive Technology by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: China 16-Year Perspective for Assisted Reproductive Technology by Type - Percentage Breakdown of Value Sales for In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types for the Years 2014, 2024 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: China 16-Year Perspective for Assisted Reproductive Technology by Procedure - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor for the Years 2014, 2024 & 2030
  • EUROPE
    • Assisted Reproductive Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Assisted Reproductive Technology by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Assisted Reproductive Technology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Assisted Reproductive Technology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for Assisted Reproductive Technology by Type - Percentage Breakdown of Value Sales for In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types for the Years 2014, 2024 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Europe 16-Year Perspective for Assisted Reproductive Technology by Procedure - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor for the Years 2014, 2024 & 2030
  • FRANCE
    • Assisted Reproductive Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 89: France Recent Past, Current & Future Analysis for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: France 16-Year Perspective for Assisted Reproductive Technology by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: France 16-Year Perspective for Assisted Reproductive Technology by Type - Percentage Breakdown of Value Sales for In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types for the Years 2014, 2024 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: France 16-Year Perspective for Assisted Reproductive Technology by Procedure - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor for the Years 2014, 2024 & 2030
  • GERMANY
    • Assisted Reproductive Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Germany 16-Year Perspective for Assisted Reproductive Technology by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Germany 16-Year Perspective for Assisted Reproductive Technology by Type - Percentage Breakdown of Value Sales for In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types for the Years 2014, 2024 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Germany 16-Year Perspective for Assisted Reproductive Technology by Procedure - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Italy 16-Year Perspective for Assisted Reproductive Technology by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Italy 16-Year Perspective for Assisted Reproductive Technology by Type - Percentage Breakdown of Value Sales for In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types for the Years 2014, 2024 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Italy 16-Year Perspective for Assisted Reproductive Technology by Procedure - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Assisted Reproductive Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 116: UK Recent Past, Current & Future Analysis for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: UK 16-Year Perspective for Assisted Reproductive Technology by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: UK 16-Year Perspective for Assisted Reproductive Technology by Type - Percentage Breakdown of Value Sales for In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types for the Years 2014, 2024 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: UK 16-Year Perspective for Assisted Reproductive Technology by Procedure - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Europe 16-Year Perspective for Assisted Reproductive Technology by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Europe 16-Year Perspective for Assisted Reproductive Technology by Type - Percentage Breakdown of Value Sales for In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types for the Years 2014, 2024 & 2030
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Europe 16-Year Perspective for Assisted Reproductive Technology by Procedure - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Assisted Reproductive Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Asia-Pacific 16-Year Perspective for Assisted Reproductive Technology by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Asia-Pacific 16-Year Perspective for Assisted Reproductive Technology by Type - Percentage Breakdown of Value Sales for In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types for the Years 2014, 2024 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Asia-Pacific 16-Year Perspective for Assisted Reproductive Technology by Procedure - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Rest of World 16-Year Perspective for Assisted Reproductive Technology by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Rest of World Historic Review for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Rest of World 16-Year Perspective for Assisted Reproductive Technology by Type - Percentage Breakdown of Value Sales for In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types for the Years 2014, 2024 & 2030
    • TABLE 149: Rest of World Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Rest of World Historic Review for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Rest of World 16-Year Perspective for Assisted Reproductive Technology by Procedure - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제